Endogenous Activated Protein C Predicts Hemorrhagic Transformation and Mortality after Tissue Plasminogen Activator Treatment in Stroke Patients

Publisher： Karger

E-ISSN： 1421-9786|28|2|143-150

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.28, Iss.2, 2009-06, pp. : 143-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin Use and Functional Outcome after Tissue Plasminogen Activator Treatment in Acute Ischaemic Stroke

By  

Cerebrovascular Diseases, Vol. 29, Iss. 3, 2010-01 ,pp. : 263-267

Karger

Access to resources Recommend Favorite

Recanalization within One Hour after Intravenous Tissue Plasminogen Activator Is Associated with Favorable Outcome in Acute Stroke Patients

By  

European Neurology, Vol. 63, Iss. 6, 2010-06 ,pp. : 331-336

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke

By  

Case Reports in Neurology, Vol. 1, Iss. 1, 2009-06 ,pp. : 20-23

Karger

Access to resources Recommend Favorite

Tissue plasminogen activator, its fast acting plasma inhibitor and protein C after renal transplantation

By Brunkwall J.   Bergqvist D.   Almer L.-O.   Nilsson I.M.  

Thrombosis Research, Vol. 77, Iss. 1, 1995-01 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite